Dr Nick Ede has over 30 years’ peptide vaccine and drug development experience. He was formerly CEO of globally recognised peptide and drug development service company Mimotopes Pty Ltd. Prior to that he was VP Chemistry at Chiron Corp (now Novartis) heading medicinal and combinatorial chemistry programs, and was a Research Fellow with the CRC for Vaccine Technology pioneering infectious disease and cancer peptide vaccines.